{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:37:25Z","timestamp":1774589845091,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005934","name":"Malm\u00f6 University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005934","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Opioid agonist treatment (OAT) is a highly effective treatment option for people with opioid use disorder. The potent medications used create dilemmas regarding low or high thresholds to access treatment, patient autonomy and regulations. OAT in Scania County in the south of Sweden has seen the implementation of regulatory changes resulting in liberalization through a patient choice model and increased access to treatment. In this setting, in which OAT has developed from high threshold to low threshold because of policy changes at both national and local levels, we aimed to analyze how patients and staff view the risks and benefits of OAT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted qualitative interviews with 32 OAT patients and 15 OAT staff in Malm\u00f6, Sweden. We analyzed the data with a thematic analysis approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients reported that OAT helped them to \u201cstabilize\u201d their lives although many felt a sense of being locked into treatment, which acted as a barrier to normalization. A significant risk was being offered illicit drugs by patients and dealers when visiting the clinic. Patients who had enrolled in OAT before liberalization found current guidelines too lenient and expressed worry that persons being enrolled were too young. Staff viewed liberalization with some ambivalence, with a positive view of increased access to OAT, although they had worries about the enrollment of young patients and difficulties supporting patients with ongoing drug use. Staff also viewed the sale of drugs in and outside of clinics as a significant problem. Some staff viewed medicines as the most important aspect of OAT, while others positioned the social support as most important.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Patient and staff perspectives were relatively congruent as they highlighted substantial risks regarding drug dealing at OAT clinics and were ambivalent toward the liberalization of OAT guidelines and the increased access to OAT. Liberalization impacted both patients and staff in their everyday lives and in professional practice, in a setting where OAT is both a desirable treatment and sometimes the basis of a problematic drug scene.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01197-w","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T01:39:49Z","timestamp":1743817189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Desirable treatment or a problematic drug scene? \u2013 An interview study of patients\u2019 and professionals\u2019 views on the risks and benefits of liberalized opioid agonist treatment"],"prefix":"10.1186","volume":"22","author":[{"given":"Johan","family":"Nordgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torkel","family":"Richert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"1197_CR1","unstructured":"Andersson L. Problematisk opioidanv\u00e4ndning: Om opioidrelaterade D\u00f6dsfall och LARO i S\u00f6dra Sverige [Problematic opioid use. Opioid-related deaths and opioid substitution treatment in southern Sweden]. PhD diss. Malm\u00f6 University; 2021."},{"issue":"3","key":"1197_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/14550725221075003","volume":"39","author":"L Andersson","year":"2022","unstructured":"Andersson L. A transition of power in opioid substitution treatment: clinic managers\u2019 views on the consequences of a patient choice reform. Nordic Stud Alcohol Drugs. 2022;39(3):279\u2013300. https:\/\/doi.org\/10.1177\/14550725221075003.","journal-title":"Nordic Stud Alcohol Drugs"},{"issue":"2","key":"1197_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/09687637.2019.1591342","volume":"27","author":"L Andersson","year":"2020","unstructured":"Andersson L, Johnson B. Patient choice as a means of empowerment in opioid substitution treatment: A case from Sweden. Drugs: Educ Prev Policy. 2020;27(2):105\u201317. https:\/\/doi.org\/10.1080\/09687637.2019.1591342.","journal-title":"Drugs: Educ Prev Policy"},{"issue":"2","key":"1197_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1005574918294","volume":"24","author":"P Bourgois","year":"2000","unstructured":"Bourgois P. Disciplining addictions: the Bio-politics of methadone and heroin in the united States. Cult Med Psychiatry. 2000;24(2):165\u201395. https:\/\/doi.org\/10.1023\/A:1005574918294.","journal-title":"Cult Med Psychiatry"},{"key":"1197_CR5","unstructured":"Danermark B, Ekstr\u00f6m M, Jakobsen L, Karlsson C, J. Explaining society: critical realism in the social sciences. Routledge; 2002."},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2018.03.052","volume":"188","author":"B Eastwood","year":"2018","unstructured":"Eastwood B, Strang J, Marsden J. Continuous opioid substitution treatment over five years: heroin use trajectories and outcomes. Drug Alcohol Depend. 2018;188:200\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.052.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1197_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1332\/174426409X463794","volume":"5","author":"M Ekendahl","year":"2009","unstructured":"Ekendahl M. The construction of maintenance treatment legitimacy: A discourse analysis of a policy shift. Evid Policy: J Res Debate Pract. 2009;5(3):247\u201365. https:\/\/doi.org\/10.1332\/174426409X463794.","journal-title":"Evid Policy: J Res Debate Pract"},{"issue":"1","key":"1197_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"D Frank","year":"2021","unstructured":"Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. It\u2019s like \u2018liquid handcuffs: the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients\u2019 lives. Harm Reduct J. 2021;18(1):88. https:\/\/doi.org\/10.1186\/s12954-021-00535-y.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1197_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1360-0443.2006.01714.x","volume":"102","author":"A Fugelstad","year":"2007","unstructured":"Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007;102(3):406\u201312. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01714.x.","journal-title":"Addiction"},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"108651","DOI":"10.1016\/j.drugalcdep.2021.108651","volume":"221","author":"NY Hall","year":"2021","unstructured":"Hall NY, Le L, Majmudar I, Mihalopoulos C. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug Alcohol Depend. 2021;221:108651. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108651.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1197_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1049732311432718","volume":"22","author":"J Harris","year":"2012","unstructured":"Harris J, McElrath K. Methadone as social control: institutionalized stigma and the prospect of recovery. Qual Health Res. 2012;22(6):810\u201324. https:\/\/doi.org\/10.1177\/1049732311432718.","journal-title":"Qual Health Res"},{"key":"1197_CR12","doi-asserted-by":"publisher","unstructured":"Jakobsen JS, Kloster ML, Christensen L, Johansen KS, Kappel N, Kronb\u00e6k M, Fahn\u00f8e KR, Houborg E. Trade-offs in substitution treatment: A qualitative study of an opioid substitution therapy clinic as an enabling and a Risk-Environment. Contemp Drug Probl. 2021;00914509211058988. https:\/\/doi.org\/10.1177\/00914509211058988.","DOI":"10.1177\/00914509211058988"},{"key":"1197_CR13","unstructured":"Johnson B. Developments in maintenance treatment policy and practice in Sweden 1987\u20132006. On the margins: nordic alcohol and drug treatment 1885\u20132007. Volume 50. Nordic Centre for Alcohol and Drug Research; 2007. pp. 259\u201387."},{"issue":"1","key":"1197_CR14","first-page":"46","volume":"17","author":"B Johnson","year":"2010","unstructured":"Johnson B. Risker och Sidoeffekter i l\u00e4kemedelsassisterad rehabilitering av opioidberoende: En Forsknings\u00f6versikt [Risks and side effects in drug assisted rehabilitation of opioid dependency: a review of the research]. Socialvetenskaplig Tidskrift. 2010;17(1):46\u201366.","journal-title":"Socialvetenskaplig Tidskrift"},{"key":"1197_CR15","doi-asserted-by":"publisher","unstructured":"Johnson B, Richert T. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors. Int J Drug Policy. 2015a;26(2):183\u2013190. https:\/\/doi.org\/10.1016\/j.drugpo.2014.10.003.","DOI":"10.1016\/j.drugpo.2014.10.003"},{"key":"1197_CR16","doi-asserted-by":"publisher","unstructured":"Johnson B, Richert T. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: The case of Sweden. Harm Reduction J. 2015b;12(1):12. https:\/\/doi.org\/10.1186\/s12954-015-0037-2.","DOI":"10.1186\/s12954-015-0037-2"},{"issue":"4","key":"1197_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/16066359409005200","volume":"1","author":"SS Jones","year":"1994","unstructured":"Jones SS, Power R, Dale A. The patient\u2019s charter: drug user\u2019s views on the ideal methadone programme. Addict Res. 1994;1(4):323\u201334. https:\/\/doi.org\/10.3109\/16066359409005200.","journal-title":"Addict Res"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","volume":"161","author":"G Kourounis","year":"2016","unstructured":"Kourounis G, Richards BDW, Kyprianou E, Symeonidou E, Malliori M-M, Samartzis L. Opioid substitution therapy: Lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.021.","journal-title":"Drug Alcohol Depend"},{"key":"1197_CR19","unstructured":"Kvale S, Brinkmann S. InterViews: learning the craft of qualitative research interviewing. SAGE; 2009."},{"issue":"6","key":"1197_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/09595230801935706","volume":"27","author":"A Madden","year":"2008","unstructured":"Madden A, Lea T, Bath N, Winstock AR. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug Alcohol Rev. 2008;27(6):671\u20138. https:\/\/doi.org\/10.1080\/09595230801935706.","journal-title":"Drug Alcohol Rev"},{"key":"1197_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","author":"RP Mattick","year":"2009","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Reviews. 2009. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2. 3.","journal-title":"Cochrane Database Syst Reviews"},{"key":"1197_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.socscimed.2015.04.008","volume":"133","author":"R McNeil","year":"2015","unstructured":"McNeil R, Kerr T, Anderson S, Maher L, Keewatin C, Milloy MJ, Wood E, Small W. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Soc Sci Med. 2015;133:168\u201376. https:\/\/doi.org\/10.1016\/j.socscimed.2015.04.008.","journal-title":"Soc Sci Med"},{"key":"1197_CR23","doi-asserted-by":"crossref","unstructured":"Morse JM. Sampling in grounded theory. In: Bryant A, Charmaz K, editors. The SAGE handbook of grounded theory. SAGE; 2010. pp. 229\u201344.","DOI":"10.4135\/9781848607941.n11"},{"key":"1197_CR24","doi-asserted-by":"publisher","unstructured":"Nordgren J, Monwell B, Johnson B, Gunnarsson NV, Capusan AJ. Healthcare staff\u2019s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study. Addict Sci Clinic Practice. 2024;19(1):25. https:\/\/doi.org\/10.1186\/s13722-024-00458-6","DOI":"10.1186\/s13722-024-00458-6"},{"issue":"2","key":"1197_CR25","doi-asserted-by":"publisher","first-page":"e12275","DOI":"10.1111\/nin.12275","volume":"26","author":"P O\u2019Byrne","year":"2019","unstructured":"O\u2019Byrne P, Jeske Pearson C. Methadone maintenance treatment as social control: analyzing patient experiences. Nurs Inq. 2019;26(2):e12275. https:\/\/doi.org\/10.1111\/nin.12275.","journal-title":"Nurs Inq"},{"issue":"5","key":"1197_CR26","doi-asserted-by":"publisher","first-page":"e0232086","DOI":"10.1371\/journal.pone.0232086","volume":"15","author":"AM O\u2019Connor","year":"2020","unstructured":"O\u2019Connor AM, Cousins G, Durand L, Barry J, Boland F. Retention of patients in opioid substitution treatment: A systematic review. PLoS ONE. 2020;15(5):e0232086. https:\/\/doi.org\/10.1371\/journal.pone.0232086.","journal-title":"PLoS ONE"},{"issue":"6","key":"1197_CR27","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.drugpo.2013.10.001","volume":"24","author":"FJM Petersson","year":"2013","unstructured":"Petersson FJM. Excusing exclusion: accounting for rule-breaking and sanctions in a Swedish methadone clinic. Int J Drug Policy. 2013;24(6):e99\u2013104. https:\/\/doi.org\/10.1016\/j.drugpo.2013.10.001.","journal-title":"Int J Drug Policy"},{"key":"1197_CR28","unstructured":"Ritchie J, Spencer L, O\u2019Connor W. Carrying out qualitative analysis. In: Ritchie J, Lewis J, editors. Qualitative research practice: A guide for social science students and researchers. SAGE; 2003. pp. 219\u201362."},{"key":"1197_CR29","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ"},{"issue":"2","key":"1197_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/v10199-012-0012-0","volume":"29","author":"B Svensson","year":"2012","unstructured":"Svensson B, Andersson M. Involuntary discharge from medication-assisted treatment for people with heroin addiction \u2013 patients\u2019 experiences and interpretations. Nordic Stud Alcohol Drugs. 2012;29(2):173\u201393. https:\/\/doi.org\/10.2478\/v10199-012-0012-0.","journal-title":"Nordic Stud Alcohol Drugs"},{"issue":"4","key":"1197_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/016059760402800404","volume":"28","author":"LG Vigilant","year":"2004","unstructured":"Vigilant LG. The stigma paradox in methadone maintenance: Na\u00efve and positive consequences of a treatment punishment approach to opiate addiction. Humanity Soc. 2004;28(4):403\u201318. https:\/\/doi.org\/10.1177\/016059760402800404.","journal-title":"Humanity Soc"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01197-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01197-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01197-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T03:05:41Z","timestamp":1743822341000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01197-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01197-w","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}